S. C. Zhang

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

B. Han, K. Li, P. Yu, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of the GHR gene genetic variation in Chinese indigenous goat breeds

S. Zhao, W. Bai, Z. H. Zhao, 2010, Molecular Biology Reports.